Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register AFT Pharmaceuticals for InfoPages here.
AFT Pharmaceuticals - Latest News [Page 1]
AFT Agrees Distribution For Crystaderm In China
Tuesday, 9 July 2024, 9:29 am | AFT Pharmaceuticals
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today announces an agreement with Hainan Haiyao Co. Ltd (Shenzhen Stock Exchange SZ:000566) to distribute Crystaderm® cream in China, the second largest pharma market in the world*. More >>
AFT Finalises Refinancing And Gives Trading Update
Monday, 23 March 2020, 11:03 am | AFT Pharmaceuticals
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces it has concluded an agreement with the Bank of New Zealand (BNZ) to refinance its current six-year CRG loan facility maturing on 31 March 2020. This follows the term sheet concluded with the BNZ which ... More >>
AFT welcomes new codeine medicine restrictions
Thursday, 5 December 2019, 9:41 am | AFT Pharmaceuticals
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes Medsafe’s decision to classify all medicines containing codeine as prescription medicines. More >>
AFT and SETEK sign medicinal cannabis MoU
Tuesday, 8 October 2019, 9:08 am | AFT Pharmaceuticals
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) and New Zealand medicinal cannabis company SETEK today announce they have signed a memorandum of understanding (MoU) to work together in the research, development and commercialisation of medicinal cannabis ... More >>
AFT Pharmaceuticals completes first deal in South America
Thursday, 20 June 2019, 2:00 pm | AFT Pharmaceuticals
AFT Pharmaceuticals’ completes first deal in South America AFT signs Maxigesic® Licensing Agreement with Barcelona-based Galenicum Vitae S.L.U for Colombia, Peru and Chile. More >>
AFT Pharmaceuticals establishes new borrowing facilities
Wednesday, 22 May 2019, 11:36 am | AFT Pharmaceuticals
AFT Pharmaceuticals (AFT) today announces it has established a NZ$15 million interim banking facility with the BNZ, enabling the company to commence refinancing its borrowings at more attractive rates. The new facility uses the existing security arrangements ... More >>
AFT Pharmaceuticals on track to return to profitability
Thursday, 22 November 2018, 9:28 am | AFT Pharmaceuticals
AFT Pharmaceuticals, manufacturer of the Maxigesic painkiller, significantly shrunk its first half loss to $0.1million from $6.7 million in the prior period, saying it remains on track to return to profitability in this financial year. More >>
Prescription-only codeine medicines in New Zealand welcomed
Thursday, 18 January 2018, 12:13 pm | AFT Pharmaceuticals
Prescription-only codeine medicines in New Zealand welcomed Yesterday the Medicines Classification Committee announced its recommendation that all codeine combination medicines, both analgesics and those used for cough and colds, should be up-scheduled ... More >>
AFT Pharmaceuticals celebrates 20 years of success
Friday, 1 September 2017, 10:08 am | AFT Pharmaceuticals
Twenty years ago this week, husband and wife Dr Hartley Atkinson and Marree Atkinson, started AFT Pharmaceuticals (AFT) in a room off their home garage. More >>
Maxigesic now licensed in 124 countries worldwide
Thursday, 20 July 2017, 12:52 pm | AFT Pharmaceuticals
AFT Pharmaceutical’s painkiller Maxigesic now licensed in 124 countries worldwide AFT Pharmaceuticals (‘AFT’) has added to its existing agreements in concluding an alliance with a private European pharmaceutical company, Amicus SA Switzerland ... More >>
AFT Pharmaceuticals In-Licenses NovaTears® in Australia & NZ
Tuesday, 21 March 2017, 11:37 am | AFT Pharmaceuticals
AFT Pharmaceuticals (AFT) has completed a licensing agreement with Novaliq, a German specialty pharmaceutical company, to distribute NovaTears® in Australia and New Zealand. More >>
TGA decision will boost Maxigesic sales in Australia
Tuesday, 20 December 2016, 11:33 am | AFT Pharmaceuticals
The Australian Therapeutic Goods Administration has today confirmed an interim decision that all medicines containing codeine be rescheduled to prescription-only medicines effective 1 February 2018. More >>
We all need to play our part in reducing antibiotic use
Tuesday, 22 November 2016, 11:18 am | AFT Pharmaceuticals
Managing Director of AFT Pharmaceuticals, Dr Hartley Atkinson, says that the pharmaceutical industry needs to take a leading role in helping reduce antibiotic use. More >>
New agreement for AFT Pharmaceuticals with Belgian Pharma
Friday, 23 September 2016, 11:39 am | AFT Pharmaceuticals
AFT Pharmaceuticals (‘AFT’) has executed an alliance agreement with privately-owned pharmaceutical company, Therabel Pharma NV (‘Therabel’), to license the product line of its patented combination painkiller, Maxigesic, to Belgium and Luxembourg. More >>
AFT Pharmaceuticals strengthens Asian operations
Tuesday, 10 May 2016, 11:32 am | AFT Pharmaceuticals
AFT Pharmaceuticals (AFT) is continuing to build its business operations in South East Asia by moving to the appointment of a Business Manager based in its Kuala Lumpur office in Malaysia. More >>
Maxigesic to carry Gold Cross logo
Friday, 18 March 2016, 11:12 am | AFT Pharmaceuticals
Australia and New Zealand pharmaceutical company, AFT Pharmaceuticals, has today announced that specific 24 tablet packets of its Maxigesic analgesic will soon carry the Pharmacy Guild of Australia’s ‘Gold Cross’ logo. More >>
AFT Pharmaceuticals lists on the NZX Main Board and ASX
Tuesday, 22 December 2015, 2:17 pm | AFT Pharmaceuticals
Shares in AFT Pharmaceuticals Limited (“AFT”), began trading on the NZX Main Board and ASX today following the successful IPO that raised $35.6 million through the issue and sale of new and existing shares. More >>
AFT Pharmaceuticals considering an IPO
Friday, 9 October 2015, 10:02 am | AFT Pharmaceuticals
AFT Pharmaceuticals considering an IPO to accelerate international growth \ Growing New Zealand and Australia based multinational pharmaceutical company, AFT Pharmaceuticals, has announced today that it is considering an initial public offering and listing ... More >>
Further US investment in AFT Pharmaceuticals
Thursday, 28 May 2015, 9:23 am | AFT Pharmaceuticals
Specialty Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd (AFT), has finalised a follow-on equity capital raise with CRG (formerly Capital Royalty L.P.), Atkinson family, AFT board members, and a group of specialist pharma ... More >>
Doctors have alternatives to topical treatments
Thursday, 19 March 2015, 1:13 pm | AFT Pharmaceuticals
Infectious disease experts this week drew attention to the growing link between topical antibiotic treaments in New Zealand and the superbug MRSA. More >>
